Samjo Management’s HTG Molecular Diagnostics HTGM Stock Holding History
Bought
Maintained
Sold
Other funds holding HTGM
Samjo Management's HTGM Position: Q2 2022 in Review
Samjo Management sold out of HTG Molecular Diagnostics (HTGM) in Q2 2022, closing a stake of 33,747 shares — an estimated $563K sold.
Samjo Management first reported a position in HTGM in Q4 2020 and held it in 6 quarters. The position peaked at $3.77M in Q3 2021. 21 funds tracked by Wall St. Rank hold HTGM as of Q2 2022.
- Samjo Management reported no remaining HTG Molecular Diagnostics position as of Q2 2022 after selling out during the quarter.
- Samjo Management sold 33,747 HTG Molecular Diagnostics shares in Q2 2022, an estimated $563K.
- Samjo Management first reported a position in HTG Molecular Diagnostics in Q4 2020 and held it in 6 quarters.
- Samjo Management's HTG Molecular Diagnostics position peaked at $3.77M in Q3 2021.
- 21 funds tracked by Wall St. Rank held HTG Molecular Diagnostics as of Q2 2022.
Based on Samjo Management's 13F filing for Q2 2022, filed 4 Aug 2022.